Quantcast Mohamed Industry News
mohamed industry news By
mohamed industry news >> CANCER February 07, 2016 members login here
>>  CANCER
A cancer startup just raised millions from a pharmaceutical giant, and it could
Business Insider Australia - 1/6/2016
A cancer startup just raised millions in a funding round led by a pharmaceutical giant. That could be the sign of bigger things to come. While cloud-based cancer software startup Flatiron Health
     Add Comment

Sun BioPharma, Inc. Announces Dosing of First Patient in Phase 1 Clinical Study
Reuters - 1/6/2016
Developing a disruptive therapeutics platform targeting large unmet medical needs; First-in-class proprietary polyamine compound designed specifically for pancreatic disease; Anticipates Entering the
     Add Comment

Study shows Capella Therapeutics experimental compound accumulates in the brain
Reuters - 1/6/2016
PR Newswire SAN DIEGO, Jan. 6, 2016 SAN DIEGO , Jan. 6, 2016 /PRNewswire/ -- Research presented at the 4 th American Association for Cancer Research (AACR) – International Association for the
     Add Comment

ERYTECH Announces Third DSMB Safety Review and Continuation of Its Phase 2b Study
Bloomberg - 1/6/2016
LYON, France--(BUSINESS WIRE)--Jan. 6, 2016-- Regulatory News: ERYTECH (Paris:ERYP) (ADR:EYRYY) (Euronext Paris: FR0011471135 - ERYP), the French biopharmaceutical company that develops innovative
     Add Comment

ERYTECH Announces Third DSMB Safety Review and Continuation of Its Phase 2b Study
Reuters - 1/6/2016
ERYTECH Announces Third DSMB Safety Review and Continuation of Its Phase 2b Study in Acute Myeloid Leukemia Regulatory News: ERYTECH (Paris:ERYP) (ADR:EYRYY) (Euronext Paris: FR0011471135
ERYtech Pharma Announces Third DSMB Safety Review And Continuation Of Its Phase BioSpace
ERYTECH :  Announces Third DSMB Safety Review and Continuation of Its Phase 2b Study 4 Traders
all 5 news articles >>      Add Comment

Coalition Of Physicians And Patient Groups Rally In Response To USPSTF Call For
Reuters - 1/6/2016
Groups emphasize need for risk stratification, added emphasis on harms of not-screening PR Newswire LINTHICUM, Md., Jan. 6, 2016 LINTHICUM, Md., Jan. 6, 2016 /PRNewswire-USNewswire/ -- In response to
     Add Comment

Innocrin Pharmaceuticals, Inc. Granted Fast Track Designation by FDA for VT-464
Bloomberg - 1/6/2016
Seviteronel (VT-464) to be presented in three sessions at the ASCO Genitourinary (ASCO GU) Cancer Symposium to be held in San Francisco, California January 7- 9, 2016 RESEARCH TRIANGLE PARK, N.C.--(BUSINESS
     Add Comment

CBS Health: Twins study sheds light on family risk for cancer
CBS News - 1/6/2016
A new study of twins sheds light on the shared roles of genetics and environment. Having an identical twin diagnosed with cancer increases the other twin's risk of developing not just that type but
     Add Comment

Twins study sheds light on family risk for cancer
CBS News - 1/6/2016
A new study of twins sheds light on the shared roles of genetics and environment. Having an identical twin diagnosed with cancer increases the other twin's risk of developing not just that type but
     Add Comment

eFFECTOR Therapeutics Initiates Dosing in Phase 1/2 Clinical Trial of eFT508 in
Reuters - 1/6/2016
PR Newswire SAN DIEGO, Jan. 6, 2016 SAN DIEGO , Jan. 6, 2016 /PRNewswire/ -- eFFECTOR Therapeutics, Inc., a biopharmaceutical company developing selective translation regulators for the treatment
eFFECTOR Initiates Dosing In Phase 1/2 Clinical Trial Of eFT508 In Solid Tumors BioSpace
all 1 news articles >>      Add Comment

Peregrine Pharmaceuticals and National Comprehensive Cancer Network (NCCN) Form
Reuters - 1/6/2016
TUSTIN, Calif., Jan. 06, 2016 (GLOBE NEWSWIRE) -- Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) (NASDAQ:PPHMP), a biopharmaceutical company focused on developing therapeutics to stimulate the body's
     Add Comment

X-Chem and MD Anderson Cancer Center Enter Partnership to Discover Novel, Small
Reuters - 1/6/2016
X-Chem and MD Anderson Cancer Center Enter Partnership to Discover Novel, Small Molecule Therapies for Cancer -- Partnership Deploys X-Chem’s DEX™ Platform and Proprietary Library
     Add Comment

Washington University in St. Louis Initiates Clinical Study of Verastem’s VS-6063
Reuters - 1/6/2016
Washington University in St. Louis Initiates Clinical Study of Verastem’s VS-6063 in Combination with Merck’s Pembrolizumab and Gemcitabine in Pancreatic Cancer Verastem, Inc. (NASDAQ:
Washington University in St. Louis Initiates Clinical Study of Verastem's VS-6063 StockHouse USA
all 1 news articles >>      Add Comment

Flatiron Health Raises $175 Million Series C Round to Further Bolster its OncologyCloudTM
Reuters - 1/6/2016
Flatiron Health Raises $175 Million Series C Round to Further Bolster its OncologyCloud TM Software Platform for Providers and Accelerate Personalized Medicine Flatiron Health
Flatiron Health Raises and#36;175 Million Series C Round to Further Bolster its SPi World News
all 1 news articles >>      Add Comment

Insights on Immuno-Oncology Drug Development and the Field's True Potential
CNBC - 1/6/2016
BioPharm Insight’s Exclusive Report on Immuno-Oncology BOSTON--(BUSINESS WIRE)-- BioPharm Insight, the most comprehensive life science market intelligence and analytics solution, recently released
     Add Comment

Insights on Immuno-Oncology Drug Development and the Field’s True Potential
Reuters - 1/6/2016
Insights on Immuno-Oncology Drug Development and the Field’s True Potential BioPharm Insight’s Exclusive Report on Immuno-Oncology BioPharm Insight, the most comprehensive life science market
     Add Comment

BRIEF-Transgene says first patient randomized in phase 3 trial for Pexa-VEC in advanced
Reuters UK - 1/6/2016
Jan 6 Transgene SA : * Announces first patient randomized in multinational phase 3 trial for Pexa-VEC oncolytic immunotherapy in advanced liver cancer Source text for Eikon: Further company coverage:
     Add Comment

Pregnant mother with cancer decided to delay treatment, gives birth to healthy baby
Kicker Daily News - 1/6/2016
Photo Credit: The Mirror A mother gets diagnosed with cancer while three weeks pregnant, but decides to delay therapy and continue the pregnancy Christiana Ensam-Taiwo got an early Christmas present
     Add Comment

Patient given wrong cancer diagnosis
BBC - 1/5/2016
A hospital has apologised for wrongly diagnosing a patient with bowel cancer. The Royal Cornwall Hospitals Trust said the incorrect diagnosis was given in an automatically generated letter sent in November.
     Add Comment

Lion Biotechnologies submits Investigational New Drug Application with US FDA for
Bloomberg - 1/5/2016
Lion Biotechnologies (NasdaqGM:LBIO) revealed on Monday that it has filed an investigational new drug (IND) application with the US Food and Drug Administration to conduct clinical trials of LN-145 in
     Add Comment

Acute Market Reports: Global Small-Cell Lung Cancer Market Clinical Trials Review,
Bloomberg - 1/5/2016
Summary GlobalData's clinical trial report, "Small-Cell Lung Cancer Global Clinical Trials Review, H2, 2015" provides an overview of Small-Cell Lung Cancer clinical trials scenario. This report provides
     Add Comment

BRIEF-Nanobiotix starts new research program in Immuno Oncology with NBTXR3
Reuters - 1/5/2016
Jan 5 Nanobiotix SA : * Nanobiotix starts a new research program in Immuno Oncology with its lead product NBTXR3 Source text: bit.ly/1INNAoN Further company coverage: (Gdynia Newsroom)
     Add Comment

BRIEF-Nanobiotix starts new research program in Immuno Oncology with NBTXR3
Reuters UK - 1/5/2016
Thomson Reuters is the world's largest international multimedia news agency, providing investing news , world news , business news , technology news , headline news, small business news , news alerts,
     Add Comment

Nanobiotix Starts a New Research Program, in Immuno Oncology, with Its Lead Product
Reuters - 1/5/2016
Nanobiotix Starts a New Research Program, in Immuno Oncology, with Its Lead Product NBTXR3 Regulatory News: NANOBIOTIX (Paris:NANO) (Euronext: NANO – ISIN: FR0011341205) , a late
Nanobiotix says initiating immuno-oncology research with lead product Pharma Letter
NANOBIOTIX : starts a new research program in Immuno Oncology with its lead product 4 Traders
all 3 news articles >>      Add Comment

New Year's Resolution #1: Practice Safe Skin to Prevent Skin Cancer
Reuters - 1/4/2016
Melanoma Foundation of New England Launches Nationwide Program to Offer Public Sunscreen Dispensers in Outdoor Recreation Areas PR Newswire BOSTON, Jan. 4, 2016 BOSTON , Jan. 4, 2016 /PRNewswire-USNewswire/
     Add Comment

Already a member? Sign in
Email Address:
Password:
Forget your password?

Build a News Circle   |   Get News Briefings   |   Congoo News Home   |   Get the Netpass
About Congoo   |   Terms of Use   |   Privacy Policy   |   Need Help?   |   Site Map
Copyright ©2016 Congoo.com. All Rights Reserved.